Experts of the Pharmacoeconomics Department conducted a “Study on Best Practices in the Public Procurement of Medicines”, which was commissioned by the European Commission. The study explored how…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
ASCERTAIN: New Horizon Europe research project to improve the affordability and sustainability of innovative health technologies
The Austrian National Public Health Institute is pleased to annouce to be part of the ASCERTAIN consortium: The affordability of newly approved innovative health technologies (IHTs) is challenging in…
Publication of PPRI Pharma Profile for Norway 2022
The PPRI Pharma Profile on Norway provides a comprehensive overview of the Norwegian pharmaceutical pricing and reimbursement system. It is part of the PPRI Pharma Profile series which was developed…